Stay updated on Pembrolizumab in EOC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in EOC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in EOC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The NIH announcement banner about updates and the shift from “Artificial Intelligence” to “Super Intelligence” was removed.
    Difference
    1%
    Check dated 2026-11-08T05:24:52.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The site revision label in the footer changes from v3.7.2 to v3.8.0, while the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T02:35:52.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    An NIH-wide announcement about terminology changes from “Artificial Intelligence” to “Super Intelligence” appears above the 403 error page.
    Difference
    1%
    Check dated 2026-10-25T02:38:31.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2; the page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-18T02:23:26.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The site revision identifier in the footer changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T03:17:05.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The 403 error block and Home navigation were removed, allowing the study details page (NCT02834975) to be accessed and viewed as designed.
    Difference
    0.5%
    Check dated 2026-09-27T03:08:19.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in EOC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in EOC Clinical Trial page.